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ㅋ
Rice- and chili-containing foods are common in Asia. Studies suggest that rice is completely absorbed in the small bowel, pro-
duces little intestinal gas and has a low allergenicity. Several clinical studies have demonstrated that rice-based meals are well 
tolerated and may improve gastrointestinal symptoms in functional gastrointestinal disorders (FGID). Chili is a spicy ingredient 
commonly use throughout Asia. The active component of chili is capsaicin. Capsaicin can mediate a painful, burning sensation 
in the human gut via the transient receptor potential vanilloid-1 (TRPV1). Recently, the TRPV1 expressing sensory fibers have 
been reported to increase in the gastrointestinal tract of patients with FGID and visceral hypersensitivity. Acute exposure to 
capsaicin or chili can aggravate abdominal pain and burning in dyspepsia and IBS patients.  Whereas, chronic ingestion of nat-
ural capsaicin agonist or chili has been shown to decrease dyspeptic and gastroesophageal reflux disease (GERD) symptoms. 
The high prevalence of spicy food in Asia may modify gastrointestinal burning symptoms in patients with FGID. Studies in Asia 
demonstrated a low prevalence of heartburn symptoms in GERD patients in several Asian countries. In conclusion rice is well 
tolerated and should be advocated as the carbohydrate source of choice for patients with FGID. Although, acute chili ingestion 
can aggravate abdominal pain and burning symptoms in FGID, chronic ingestion of chili was found to improve functional dys-
pepsia and GERD symptoms in small randomized, controlled studies.
(J Neurogastroenterol Motil 2010;16:131-138)
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Introduction
Complaints of gastrointestinal symptoms after food ingestion 
are common in patients with functional gastrointestinal disorders 
(FGID) and are reported in 25-64% of irritable bowel syndrome 
(IBS) patients.
1,2 IBS patients often complain of food-related gas-
trointestinal symptoms secondary to more than one specific food. 
A recent population-based study in the USA demonstrated that 
16.5% and 28.3% of IBS patients had intolerance to 1-2 food 
items and ＞ 2 items, respectively.
2 These statistics suggest that 
hyper-sensitivity to the ingestion of foods is common in IBS.  
Research studies also demonstrate that certain foods, such as chi-
li, fructose or fructan containing foods and fatty foods, can affect 
gastrointestinal motility and sensation
3,4 and induce gastro-
intestinal symptoms more than other foods.
4-6 This suggests that Sutep Gonlachanvit
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certain foods, and not just the process of eating foods, can ag-
gravate symptoms in patients with FGID. Therefore, mod-
ification of either eating habits (reducing meal size and/or the 
time of meals) or the composition of meals (avoiding specific food 
items) may benefit patients with FGID, and studies on the effects 
of food on gastrointestinal functions and symptoms are 
important.  
The effects of food ingestion on gastrointestinal symptoms in 
patients with FGID have been extensively studied, mainly in 
Western countries and with Western diets. Moreover, in-
formation regarding the effects of typical Asian foods on gastro-
intestinal symptoms of FGID is quite limited. This review will 
focus on the effects of specific but widely used Asian diets/in-
gredients, “rice and chili or spicy foods,” on gastrointestinal func-
tions and their roles on the symptoms of FGID.
Characteristics of the Asian Diet
The Asian diet is characterized by a high-carbohydrate, 
high-fiber, low-fat, and low-meat protein composition.
7 Typical 
Asian food generally consists of rice and vegetables as the major 
source of carbohydrate and fiber. Vegetable oil is a common 
source of fat, whereas fish, eggs, poultry, and pork are the main 
sources of protein. This is in contrast to Western diets, which are 
rich in animal fat and beef protein but lower in carbohydrate and 
fiber contents. In addition, Asian foods often consist of several in-
gredients, such as chili, to make the foods tastier. 
1. Role of rice and high-carbohydrate diet in FGID
In general, food can aggravate gastrointestinal symptoms by 
several mechanisms including: exaggerated physiologic re-
sponses of the gastrointestinal tract, food intolerance, allergy, in-
creased intestinal gas,
8 and modification of gut motility and 
sensation. 
Food with high-carbohydrate content may cause symptoms 
of functional bowel disorders by both allergic and non-allergic 
mechanisms. As for the latter, carbohydrate may cause gastro-
intestinal symptoms because of incomplete absorption in the 
small bowel, such as lactose mal-absorption.
9 In the allergic 
mechanism, the protein contents in the carbohydrate sources may 
cause allergic reactions to the gastrointestinal tract, such as gluten 
in wheat.
10  
Major types of carbohydrate in the human diet are: starches, 
sucrose, and lactose. They have to be digested into mono-
saccharide before being absorbed through the gut mucosa. If the 
complex-carbohydrate and monosaccharide are not completely 
absorbed into the small bowel, then these substances will enter the 
colon and will be fermented by colonic bacteria to produce gas 
and short-chain fatty acids, which may contribute to the symp-
toms reported in patients with FGID
11 such as diarrhea, gas, 
bloating, and abdominal discomfort and pain. The non-absorb-
able carbohydrates and their metabolites may induce gastro-
intestinal symptoms by their effects on gut sensation
12 and gut 
motility, such as decreased gastric tone, decreased lower esoph-
ageal sphincter pressure and accelerated small bowel transit.
13-15 
A recent study in Asia (India) demonstrated that there is a similar 
prevalence of lactose intolerance in IBS patients and healthy 
controls.
16 The authors performed lactose hydrogen breath tests 
in 124 IBS patients and 53 age- and gender-matched healthy 
controls. They found a similar prevalence of abnormal lactose hy-
drogen breath tests in IBS patients and healthy volunteers (72% 
vs. 60%). However, IBS patients developed gastrointestinal 
symptoms more often than healthy volunteers after ingestion of 
lactose (56% vs. 34%).
16 This higher rate of gastrointestinal 
symptoms suggests that there is a role of visceral hypersensitivity 
in the expression of carbohydrate mal-absorption symptoms and 
that the completeness of small intestinal absorption of carbohy-
drate is important in patients with IBS and can associate with 
their IBS symptoms. 
2 .  R i c e  i s  c o m p l e t e l y  a b s o r b e d  i n  t h e  s m a l l  i n t e s t i n e ,  
producing little gas
Major sources of complex carbohydrate or starch in the hu-
man diet are wheat, rice, oat, potato, and corn. The effects of each 
complex carbohydrate or starch on gastrointestinal symptoms de-
pend on its fiber content, its allergenicity, and the completeness of 
the small bowel digestion and absorption. In Western countries, 
wheat is the major source of carbohydrate. It may cause gastro-
intestinal symptoms by allergic reaction to gluten, the major pro-
tein component of wheat.
17,18 In a recent meta-analysis of 14 stud-
ies, patients who fulfill the criteria of IBS (n = 2,278) have a 
higher prevalence of celiac disease than controls (n = 1,926).
19 
The pooled prevalence of positive IgA-class antigliadin antibody, 
either positive endomysial antibody or tissue transglutaminase, 
and biopsy-proved celiac disease in IBS were 4.0%, 1.63%, and 
4.1%, respectively. Pooled odds ratios (95% confidence interval) 
for positive IgA-class antigliadin antibody, either positive endo-
mysial antibody or tissue transglutaminase, and biopsy-proved 
celiac disease in IBS patients compared with controls were 3.40 
(1.62-7.13), 2.94 (1.36-6.35), and 4.34 (1.78-10.6), respec- Rice and Chili in FGID
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tively.
19 This implies that, in a subgroup of IBS patients, in-
gestion of a gluten-containing diet may aggravate and avoidance 
of the diet may improve gastrointestinal symptoms.
20 Further-
more, wheat ingestion produces the highest peak of breath hydro-
gen compared to other sources of carbohydrate such as corn, oats, 
potatoes, beans, and rice in healthy humans.
21 This suggests that 
wheat carbohydrate is not completely absorbed in the small bowel 
and that it may produce gastrointestinal symptoms, independent 
of gluten hypersensitivity.
22
Rice is the major source of carbohydrate in Asian 
populations.  In contrast to wheat and other sources of carbohy-
drate, rice is completely absorbed in the small bowel and pro-
duces very little intestinal gas after ingestion.
21 A previous study 
demonstrated that the amount of hydrogen, a maker of carbohy-
drate metabolism by intestinal bacteria,
23 in breath samples after 
rice ingestion is minimally increased and not significantly differ-
ent from the fasting period.
21 Furthermore, rice has been shown 
to have a low allergenicity. Previous studies demonstrated that se-
rum IgG levels produced in reaction to several kinds of food such 
as wheat, beef, pork, lamb, soybean, shrimp, egg, and crab were 
increased in IBS patients compared to healthy humans,
24,25 but 
the serum IgG levels produced to rice in IBS patients is mild
26 or 
not increased.
25,26 A study from China in 37 IBS, 28 functional 
dyspepsia, and 20 healthy controls demonstrated that serum IgG 
antibody titers to rice was similar in IBS (28.7 ± 0.5 U/mL) and 
functional dyspepsia patients (29.5 ± 0.7 U/mL) compared to 
healthy controls (28.4 ± 0.5 U/mL). In contrast, the serum IgG 
antibody titer to wheat was increased in IBS patients (60.6 ± 3.4 
U/mL) compared to functional dyspepsia patients (49.4 ± 2.0 
U/mL) and healthy controls (48.1 ± 2.0 U/mL).
25 This low pro-
duction of IgG suggests that rice has a low allergenicity com-
pared to other common foods. 
3. Rice has lowest fiber content compared to other 
common sources of carbohydrate
It has been reported that fiber speeds up human gut transit
27 
and can improve constipation symptoms.
28 However, its benefit 
in FGID is limited. Recent meta-analysis studies on the effect of 
fiber on global symptoms of IBS patients demonstrated conflict-
ing results.
28,29 In addition, it may worsen abdominal pain and 
bloating symptoms.
28,29 In healthy humans, ingestion of fiber 
(psyllium) can delay intestinal gas transit and cause more gas re-
tention after intestinal gas perfusion.
30 Thus, a high-fiber diet 
may worsen abdominal bloating and pain by delaying intestinal 
gas transit and increasing gas production in the colon secondary 
to bacterial fermentation. In certain parts of Asia, such as in 
India, healthy controls and patients with IBS have more dietary 
fiber (51.7 and 52.3 g/day, respectively) than the recommended 
amount for the general population (20-40 g/day).
31 Therefore, 
increasing the dietary fiber consumption of functional gastro-
intestinal disorder patients in certain parts of Asia may not pro-
vide any benefit but may worsen the bloating and abdominal pain 
symptoms. 
Although the Asian diet is rich in fiber, rice - the widely used 
complex carbohydrate - has the lowest fiber content compared to 
other kinds of cereal. A previous study demonstrated that the to-
tal fiber content (insoluble + soluble fiber) of different kinds of 
cereal is lowest in rice and highest in wheat (4.1% in rice vs. 
12.5% in wheat).
32 As high-fiber may worsen abdominal pain and 
bloating symptoms, rice may be the most preferable carbohydrate 
source for functional gastrointestinal disorder patients with pre-
dominant symptoms of bloating and abdominal pain.
4. Clinical studies suggest benefits of rice-base meal in 
IBS
Rice has been the major source of carbohydrate in exclusion 
diets in several clinical studies.
33-37 These studies demonstrated 
that the exclusion diet is well tolerated and can improve IBS 
symptoms in both open and controlled studies.
33-37 A recent study 
by King et al.
38 suggests that the rice-based exclusion diet may 
improve symptoms in IBS by reducing intestinal gas production. 
The study was performed in 6 female IBS patients and 6 female 
controls by measuring 24-hour hydrogen and methane pro-
duction after ingestion of rice-based exclusion diet or standard 
diet, in a crossover controlled trial, using a whole-body 
calorimeter. The authors found that after standard diet the gas 
excretion rate and hydrogen production was higher in IBS pa-
tients (2.4 mL/min and 332 mL/24 hr, respectively) than in con-
trols (0.6 mL/min and 162 mL/24 hr). The rice-based exclusion 
diet reduced hydrogen production compared to standard diet in 
both IBS (79 vs. 332 mL/24 hr) and controls (95 vs. 162 mL/24 
hr). In addition, in IBS patients, the exclusion diet reduced 
symptoms [symptom score = 8 (5.25-10) vs. 4 (3-7)] and re-
duced the maximum gas excretion rate compared to the standard 
diet (0.5 vs. 2.4 mL/min). 
Recently, the very-low-carbohydrate strategy has been shown 
to improve IBS-D symptoms in a small open study.
39 The au-
thors found that 13 of the 17 patients who were enrolled com-
pleted the study. Ten (77%) of the patients who completed the 
study reported adequate relief of IBS symptoms. Furthermore, Sutep Gonlachanvit
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the stool frequency, stool consistency, pain scores, and quality of 
life were significantly improved. 
Because there have been reports of inadequate dietary intake 
because of food avoidance in IBS patients, the avoidance of poor-
ly-absorbed carbohydrates combined with the consumption of 
well-absorbed carbohydrates or rice may be more appropriate 
than the use of very-low-carbohydrate diets in the dietary treat-
ment strategy for IBS patients. 
All together, rice may be the best source of carbohydrate for 
patients with functional bowel disorder because of its low allerge-
nicity, its nearly complete absorption in the small bowel, and its 
low fiber content. In addition, a small crossover controlled study 
supports its benefit in IBS.
38
5. Effect of chili on FGID
Chili and spicy food are common in most Asian countries.  
The average daily chili consumption in Asian people is 2.5-8 
g/person. It is much higher than that of 0.05-0.5 g/person in 
European and American peoples.
40 Recent studies suggest that 
acute and chronic ingestion of chili can modify gastrointestinal 
symptoms in FGID.
6,41 Whether or not a high prevalence of spi-
cy food modifies gastrointestinal symptoms at the population lev-
el is not known. In addition, data on the effect of chili or spicy 
foods on FGID in Asian countries with a high prevalence of spi-
cy food have been limited.
6. Capsaicin mediated visceral nociception in FGID
The active ingredient of chili is capsaicin. Capsaicin can 
modulate gastrointestinal sensation via capsaicin or TRPV1 
receptors. These receptors have been found at different levels 
throughout the gastrointestinal tract.
42-50 Capsaicin, acid, and 
heat can stimulate the TRPV1 receptors and mediate a sensation 
of burning and pain.
51 Several studies suggested that TRPV1 re-
ceptors can mediate sensations of warmth, pressure, cramping, 
and pain in the human gut.
52 Increases in the number of TRPV1 
receptors have been found in the gut mucosa of patients with con-
ditions associated with visceral hypersensitivity, including in the 
esophagus of patients with non-erosive reflux disease (NERD),
42 
in the colon of patients with irritable bowel syndrome
53 and in the 
rectum of patients with rectal hypersensitivity.
43 Recent studies 
demonstrated that patients with FGID, including functional dys-
pepsia and irritable bowel syndrome, exhibit gut hypersensitivity 
to capsaicin or capsaicin containing chili.
6,54 Hammer et al.
54 
studied the effect of 0.75 mg capsaicin powder ingestion on gas-
trointestinal symptoms in 54 functional dyspepsia patients and 61 
healthy controls. They found that after capsaicin ingestion, nau-
sea, a flutter-like sensation, warmth and abdominal pain scores 
were higher in functional dyspepsia patients than in healthy 
volunteers. A recent study in 20 IBS-D patients demonstrated 
that ingestion of chili-containing meals produces higher abdomi-
nal pain and abdominal burning symptom scores than standard 
meals and when compared to the symptoms reported by healthy 
volunteers in response to ingestion of chili-containing meals.
6 
Studies suggest that abdominal pain and burning symptoms seem 
to be the typical gastrointestinal symptoms of capsaicin hyper-
sensitivity,
6,54 whereas abdominal bloating symptoms seems to be 
independent of the capsaicin pathways.
Low-grade inflammation in the gastrointestinal tract has 
been proposed as a major pathogenesis of FGID, especially in ir-
ritable bowel syndrome.
55 Up-regulation of TRPV1 pathways re-
sulting in visceral hypersensitivity to mechanical and chemical 
stimulations has been reported following an induction of colonic 
inflammation in an animal model.
56 In humans, gut inflammation 
has been reported to be associated with an increased number of 
TRPV1-expressing nerve fibers.
50,57 Thus, hypersensitivity of the 
TRPV1 pathways in patients with FGID is likely a result of 
low-grade inflammation and may be an important pathogenesis of 
gut hypersensitivity, abdominal pain, and abdominal burning 
symptoms in FGID.  
7. Desensitization of capsaicin receptors, its role on 
patients’ symptom profiles and treatment of FGID
It has been reported that prior exposure of esophageal muco-
sa to capsaicin solution do not affect esophageal sensation in re-
sponse to acid perfusion or to balloon distention.
58 However, the 
study evaluated the effect of single stimulation of esophageal mu-
cosa by perfusion of capsaicin solution into the esophagus and 
could not exclude the desensitization effects of capsaicin re-
ceptors in the gut mucosa after repeated exposure to capsaicin 
agonists.
It has been demonstrated that TRPV1 receptors can be de-
sensitized by repeated exposure to capsaicin.
48 Recent small stud-
ies suggested that chronic ingestion of capsaicin containing chili 
can modify dyspepsia symptoms in functional dyspepsia pa-
tients
41 and GERD symptoms in NERD
59 by decreasing dys-
peptic and GERD symptoms, respectively. Bortolotti et al.
41 
randomized 30 functional dyspepsia patients to receive 2.5 g/day 
of red pepper powder or placebo in a double-blind manner for 5 
weeks. They found that red pepper significantly improved overall 
symptom scores, epigastric pain, fullness, and nausea scores rela- Rice and Chili in FGID
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Figure 1. The prevalence of heartburn and acid regurgitation symptoms in patients with positive and negative 24-hour pH monitoring: a 
comparison of the 2 studies from Asia (A, Thailand)
62 and Europe (B, German).
61
tive to placebo. The overall symptom scores decreased from 3.3 
± 0.6 at baseline to 1.7 ± 0.2 at the end of week 5 for red chili 
treatment compared to from 3.4 ± 0.7 to 2.5 ± 0.3 for placebo 
treatment. In a preliminary study in 8 patients with NERD, red 
chili ingestion for 6 weeks significantly improved total GERD, 
heartburn, and regurgitation symptom scores compared to 
placebo.
59  The authors found that, at baseline, total GERD 
scores, heartburn, and regurgitation scores were similar compar-
ing between chili and placebo capsules (chili vs. placebo: 7.6 ± 
3.7 vs. 4.7 ± 2.8, 4.6 ± 2.3 vs. 3.2 ± 2.1, and 2.9 ± 2.4 vs. 1.5 
± 1.6, respectively). At the end of week 6, red chili significantly 
decreased GERD symptom scores (chili vs. placebo: 0.9 ± 1.2 
vs. 4.9 ± 2.4), heartburn symptom scores (0.4 ± 0.6 vs. 3.7 ± 
1.6), and food regurgitation symptom scores (0.5 ± 0.8 vs. 1.3 ± 
1.6) compared to placebo. The effects of chili ingestion on func-
tional dyspepsia and GERD symptoms were observed after the 
2nd week of treatment in both studies. The similar effects of 
chronic ingestion of red chili in functional dyspepsia and NERD 
patients suggests that capsaicin receptors play role on the devel-
opment of both functional dyspepsia and NERD symptoms and 
is consistent with previous reports of visceral hypersensitivity to 
capsaicin in functional dyspepsia
54 and increase TRPV1 re-
ceptors in NERD.
42 In contrast, a previous study in 12 healthy 
volunteers reported that chronic chili ingestion induce more gas-
troesophageal refluxes.
60 However, the duration of chili in-
gestions was too short (≤ 1 week) in relative to the other studies, 
which showed the desensitization effect of chili (5-6 weeks). 
These limited data suggest that the natural capsaicin agonist 
(chili) may have a therapeutic role for pain and burning symp-
toms in FGID and more research studies are needed to confirm 
this hypothesis. 
The effect of spicy food, which is frequently eaten in Asia, on 
the gastrointestinal symptom profiles in FGID at population lev-
el is not clearly known. Studies of GERD symptoms in Asian pa-
tients have reported a lower prevalence of heartburn compared to 
Western patients. A study of GERD symptoms in German pa-
tients who underwent 24-hour esophageal pH monitoring 
showed that both heartburn and acid regurgitation are the main 
typical GERD symptoms,
61 whereas a similar study in an Asian 
country (Thailand) with a high prevalence of spicy food reported 
only acid regurgitation, but not heartburn, as the main GERD 
symptom (Fig. 1).
62 Furthermore, epidemiologic studies in 
Asian countries, including China, Iran, and Thailand, demon-
strated lower heartburn/regurgitation symptom prevalence ra-
tios
63-66 compared to Western or developed countries with a low 
prevalence of spicy food.
67-69 However, the low heartburn/regur-
gitation symptom prevalence ratio was not observed in Korea.
70 
In Turkey, an European country with a high prevalence of spicy 
food, the prevalence of heartburn in the population is much lower 
than the prevalence of acid regurgitation (weekly heartburn vs. 
acid regurgitation: 10% vs. 15.6%, respectively).
71 When the 
studies that reported the prevalence of annual regurgitation and 
heartburn symptoms were included, studies of the American pop-
ulation reported a heartburn/regurgitation prevalence ratio of 
0.91-0.94,
68,69 whereas studies in China reported a lower ratio of 
0.34.
64 There has been no study that directly compares GERD 
symptom profiles between Asian and Western peoples or patients 
in the area of high and low prevalence of chili in the diet. Sutep Gonlachanvit
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However, the collective results of the available studies imply that 
acid or gastric content regurgitation into the esophagus in people 
in certain regions of Asia is not perceived as heartburn symptoms 
by the esophagus in the same way that heartburn symptoms are 
perceived by Western people. The high prevalence of spicy food 
may play a role in this finding, but this hypothesis has not been 
proven. The low prevalence of heartburn symptoms is not likely 
to be a misinterpretation of acid reflux symptoms in Thai people 
because acid perfusion tests produce no symptoms in most Thai 
GERD patients (GI Motility Research Unit, Chulalongkorn 
University, Thailand, un-published data). However, the heart-
burn/regurgitation symptom prevalence ratio is not lower in 
Mexico, where the prevalence of spicy food is high. This incon-
sistency suggests that not only spicy food, but also other factors, 
may influence the sensitivity of esophagus to gastro-esophageal 
reflux contents at the population level. 
In summary, capsaicin or TRPV1 receptors are involved in 
the pathogenesis of burning and pain symptoms of the gastro-
intestinal tract. Recent small studies suggest that the chronic use 
of capsaicin-containing chili can decrease heartburn and abdomi-
nal pain in GERD and dyspepsia, respectively. In addition, the 
ratio of the prevalence of heartburn/regurgitation symptoms in 
the population is lower in several parts of Asia; this lower rate 
may be related to the high prevalence of chili or spicy food. 
Conclusion
Rice seems to be the most preferable source of carbohydrate 
in patients with FGID. It has a low allergenicity and fiber con-
tent; it is also completely absorbed in the small bowel and pro-
duces little gas after ingestion. Therefore, it should be advocated 
as a major source of carbohydrate for patients with IBS and those 
with other functional GI disorders.
There has been increasing evidence to support the role of 
capsaicin receptors in the pathogenesis of symptoms of FGID. 
Preliminary studies support the role of desensitization of cap-
saicin receptors by chili, a natural capsaicin receptor agonist, for 
the treatment of functional dyspepsia and NERD. However, 
more research studies are needed to confirm this hypothesis.
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